Thrive Bioscience’s unique solutions increase the speed, quality, and cost-effectiveness of drug discovery and basic research while enabling the delivery of new therapies through improving the cell culture, stem cell culture, and tissue culture processes.
The Company was named as one of the “50 Fastest Growing Companies in 2020” by Silicon Review and one of the “20 Best Biotech Companies” in 2019 by CIO Review. With an extensive patent portfolio, the Company has been collaborating with internationally recognized researchers in large pharmaceutical, academic, and independent research organizations. These collaborations have resulted in the CellAssist, the first of a family of products for enabling reproducible cell, tissue, and suspension culture.
